New shot could bring relief to eczema sufferers
Disease control
Not yet recruiting
This study tests an injection called ADSTEM for people with moderate to severe eczema (atopic dermatitis) that hasn't improved with standard creams or pills. About 286 adults aged 19 to 70 will receive either the study drug or a placebo to see if it safely reduces skin redness, i…
Phase: PHASE3 • Sponsor: EHL Bio Co., Ltd. • Aim: Disease control
Last updated May 26, 2026 12:00 UTC